@article{f6ab6e3a0e274fdb9f9a38e7ccdfb645,
title = "Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study>",
keywords = "Anemia, Hepatitis C, Phase 2 study, Ribavirin, Safety, Taribavirin, Viramidine, Thrombocytopenia/chemically induced, Humans, Middle Aged, Polyethylene Glycols/therapeutic use, Male, Recombinant Proteins, Interferon-alpha/therapeutic use, Incidence, Neutropenia/chemically induced, Adult, Female, Hepatitis C, Chronic/drug therapy, Drug Therapy, Combination, Treatment Outcome, RNA, Viral/blood, Antiviral Agents/adverse effects, Interferon alpha-2, Aged, Anemia/chemically induced, Ribavirin/adverse effects",
author = "Gish, \{Robert G.\} and Sanjeev Arora and \{Rajender Reddy\}, K. and Nelson, \{David R.\} and Christopher O'Brien and Yi Xu and Brian Murphy",
year = "2007",
month = jul,
doi = "10.1016/j.jhep.2007.02.018",
language = "English",
volume = "47",
pages = "51--59",
journal = "Journal of Hepatology",
issn = "0168-8278",
number = "1",
}